Dermal Fillers Market size is valued at around USD 2,500 million in 2021 and is poised to grow at a significant CAGR of 10% from 2022 to 2028. The worldwide dermal fillers market will benefit from advancements in novel dermal fillers. The US Food and Drug Administration (FDA) approved many products developed for specific face areas, allowing physicians to provide customized therapy to patients. The filler is allowed to treat creases and folds on the face that are moderate to severe. Furthermore, current breakthroughs such as HA filler for subtle lip enhancement that improves lip definition without increasing lip size will encourage a greater desire for dermal filler procedures. In recent years, both industrialized and developing countries have seen a considerable increase in facilities such as clinics, medical spas, and rejuvenation centers. As a result, the business will increase due to the fast adoption of various non-invasive therapies given by these facilities, which have advantages such as cost-effectiveness and shorter treatment times. A growing number of competent specialists, such as dermatologists and plastic surgeons, will also contribute to the industry’s growth. Several players in the dermal fillers market are actively updating their research and development activities to come out with unique products and new launches. This factor will result in more revenues, eventually boosting the dermal fillers market’s growth rate.
Recent Market Developments:
In August 2020, Revance launched the RHA Collection of dermal fillers, Resilient Hyaluronic Acid, and the HintMD financial technology platform in the United States in September. This will strengthen the company’s footprint in the United States and raise demand for RHA products.
In September 2021, Suneva Medical announced that it had raised USD 15 million in the financing, which will be used to pay down existing debt and assist its growth and expansion as the leader in regenerative aesthetics.